SCHEMBL6889342

SCHEMBL6889342

CCCC(C)c1[c]c2ccccc2cc1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894355 0.90 POLB (0.31)
SCHEMBL2502578 0.86 TSHR (0.37)
SCHEMBL6893319 0.81 PPARG (0.32) PPARGPPARA
SCHEMBL6896470 0.81 LARS1 (0.31)
SCHEMBL198668 0.77 UGT2B7 (0.36)
SCHEMBL237196 0.77
SCHEMBL6895560 0.77 CYP1A2 (0.31)
SCHEMBL5500476 0.76 CSNK1E (0.33) PPARGPPARASMN1; SMN2
SCHEMBL6890600 0.76 TAAR1 (0.32)
SCHEMBL6890469 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888262-B1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AG (DE) 2004-06-02 EP disclosed
US-6521780-B1 Cycloalkylmalonic ester derivatives as potential active substances in the drugs and crop protection; combinatorial chemistry BASF AKTIENGESELLSCHAFT (DE) 2003-02-18 US disclosed
US-6469056-B1 VERY SELECTIVE INHIBITORS OF ENDOTHELIN CONVERTING ENZYME WITH ACTIVITIES IN THE PICOMOLAR RANGE FOR USE AS HYPOTENSIVE AGENTS ABBOTT LABORATORIES 2002-10-22 US disclosed
EP-0906324-B1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AG (DE) 2001-08-01 EP disclosed
US-6242583-B1 COUPLING CARBOHYDRATE COMPOUNDS IN PRESENCE OF PROMOTER TO A FUNCTIONALIZED SOLID SUPPORT BASF AKTIENGESELLSCHAFT (DE) 2001-06-05 US disclosed
EP-1023282-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR PREPARATION AND USE AS ECE-INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2000-08-02 EP disclosed
EP-1023318-A1 DIPEPTIDES FOR THE TREATMENT OF DISEASES RELATED TO THE BIOLOGICAL EFFECT OF ENDOTHELIN BASF AKTIENGESELLSCHAFT (DE) 2000-08-02 EP disclosed
WO-1999019320-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS, THEIR PREPARATION AND USE AS ECE-INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
WO-1999019346-A1 DIPEPTIDES FOR THE TREATMENT OF DISEASES RELATED TO THE BIOLOGICAL EFFECT OF ENDOTHELIN BASF AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
EP-0906324-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 EP disclosed
EP-0888262-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1999-01-07 EP disclosed
WO-1997045436-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1997-12-04 WO disclosed
WO-1997034852-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-09-25 WO disclosed